Linscomb & Williams Inc. Has $400,000 Stake in Laboratory Corporation of America Holdings (LH)

Linscomb & Williams Inc. maintained its position in shares of Laboratory Corporation of America Holdings (NYSE:LH) during the fourth quarter, Holdings Channel reports. The firm owned 3,114 shares of the company’s stock at the end of the fourth quarter. Linscomb & Williams Inc.’s holdings in Laboratory Corporation of America Holdings were worth $400,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of LH. Sumitomo Mitsui Asset Management Company LTD boosted its stake in shares of Laboratory Corporation of America Holdings by 1.4% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 7,780 shares of the company’s stock worth $1,013,000 after buying an additional 110 shares during the period. Smithfield Trust Co. bought a new stake in shares of Laboratory Corporation of America Holdings during the second quarter worth $107,000. Concert Wealth Management Inc. boosted its stake in shares of Laboratory Corporation of America Holdings by 0.4% in the second quarter. Concert Wealth Management Inc. now owns 2,393 shares of the company’s stock worth $313,000 after buying an additional 10 shares during the period. Pillar Pacific Capital Management LLC boosted its stake in shares of Laboratory Corporation of America Holdings by 2.1% in the second quarter. Pillar Pacific Capital Management LLC now owns 20,368 shares of the company’s stock worth $2,653,000 after buying an additional 420 shares during the period. Finally, Klingenstein Fields & Co. LLC boosted its stake in shares of Laboratory Corporation of America Holdings by 6.1% in the second quarter. Klingenstein Fields & Co. LLC now owns 207,603 shares of the company’s stock worth $27,044,000 after buying an additional 11,856 shares during the period. Institutional investors and hedge funds own 92.19% of the company’s stock.

Institutional Ownership by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)

Shares of Laboratory Corporation of America Holdings (NYSE:LH) traded up 0.88% during trading on Friday, hitting $135.01. The stock had a trading volume of 1,091,030 shares. The stock has a 50 day moving average price of $132.27 and a 200-day moving average price of $132.96. The stock has a market capitalization of $13.91 billion, a price-to-earnings ratio of 21.41 and a beta of 0.94. Laboratory Corporation of America Holdings has a one year low of $102.42 and a one year high of $141.32.

ILLEGAL ACTIVITY WARNING: This piece was reported by sleekmoney and is the sole property of of sleekmoney. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US and international trademark and copyright laws. The legal version of this piece can be viewed at http://sleekmoney.com/linscomb-williams-inc-has-400000-stake-in-laboratory-corporation-of-america-holdings-lh/1656731.html.

A number of analysts have weighed in on LH shares. Gabelli started coverage on Laboratory Corporation of America Holdings in a research report on Tuesday, October 25th. They issued a “buy” rating and a $180.00 price target on the stock. Zacks Investment Research cut Laboratory Corporation of America Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, October 25th. Canaccord Genuity set a $140.00 price target on Laboratory Corporation of America Holdings and gave the company a “buy” rating in a research report on Sunday, October 30th. Deutsche Bank AG reiterated a “buy” rating and issued a $170.00 price target on shares of Laboratory Corporation of America Holdings in a research report on Wednesday, January 18th. Finally, Robert W. Baird cut Laboratory Corporation of America Holdings from an “outperform” rating to a “neutral” rating and set a $138.00 price target on the stock. in a research report on Monday, February 6th. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $146.60.

Laboratory Corporation of America Holdings Company Profile

Laboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

5 Day Chart for NYSE:LH

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corporation of America Holdings (NYSE:LH).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/linscomb-williams-inc-has-400000-stake-in-laboratory-corporation-of-america-holdings-lh/1656731.html

Receive News & Ratings for Laboratory Corporation of America Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corporation of America Holdings and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *